Drug Profile
Pneumococcal vaccine conjugate
Latest Information Update: 29 Apr 2002
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Class Conjugate vaccines; Pneumococcal vaccines; Polysaccharides
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Pneumococcal infections
Most Recent Events
- 12 Jul 1999 New profile
- 12 Jul 1999 Preclinical development for Pneumococcal infections in USA (Unknown route)